Melatonite (Melatonin)

Melatonin acts as an agonist at MT1 and MT2 receptors located in the brain’s suprachiasmatic nucleus. By mimicking the natural hormone released in darkness, it signals the body that night has arrived, helping to synchronize the internal circadian clock and promote the onset of sleep without directly causing sedation.

The appropriate dose of Melatonite is determined by a qualified prescriber based on the individual’s age, condition, and response to therapy. Healthcare professionals consider factors such as severity of insomnia or travel schedule before recommending a specific dosage regimen.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Melatonite.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Melatonite. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike many prescription hypnotics that act on GABA receptors to induce sedation, melatonin works by aligning the body’s circadian rhythm. This mechanism often results in fewer next‑day residual effects, making it a preferred option for short‑term sleep disturbances and jet‑lag management.

Melatonite should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Melatonite is taken orally, typically with a glass of water. It is usually recommended to ingest the tablet about 30‑60 minutes before the desired bedtime, following the dosage instructions provided by the prescribing clinician.

Serious but rare risks include allergic reactions such as rash, swelling, or difficulty breathing, as well as mood alterations like depression or severe dizziness. Patients experiencing any of these symptoms should seek immediate medical attention.

Individuals with known hypersensitivity to melatonin or any excipients in the formulation should avoid Melatonite. Additionally, patients with uncontrolled severe renal impairment, pregnant or breastfeeding women without medical advice, and those taking medications that have major interactions with melatonin should not use it without professional guidance.